Fulgent Genetics (FLGT) Operating Leases (2019 - 2026)

Fulgent Genetics (FLGT) has 7 years of Operating Leases data on file, last reported at $6.0 million in Q1 2026.

• Quarterly Operating Leases rose 54.33% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (up 54.33% YoY) and the FY2025 annual result came in at $3.8 million, down 8.23% from the prior year.
• Operating Leases improved to $6.0 million in Q1 2026 per FLGT's latest filing, from $3.8 million in the prior quarter.
• The five-year high for Operating Leases was $8.8 million in Q4 2022, with the low at $3.6 million in Q3 2025.
• Average Operating Leases over 5 years is $5.4 million, with a median of $4.7 million recorded in 2024.
• Year-over-year, Operating Leases plunged 47.38% in 2025 and soared 54.33% in 2026.
• Fulgent Genetics' Operating Leases stood at $8.8 million in 2022, then dropped by 18.74% to $7.1 million in 2023, then tumbled by 42.35% to $4.1 million in 2024, then decreased by 8.23% to $3.8 million in 2025, then jumped by 58.9% to $6.0 million in 2026.
• Business Quant data shows FLGT's Operating Leases at $6.0 million in Q1 2026, $3.8 million in Q4 2025, and $3.6 million in Q3 2025.